WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC) (the “Company”), announced today that its Dengue virus therapeutics program is advancing at an accelerated pace. Dengue fever is gaining a firmer foothold in southern Texas, putting residents at risk for the most dangerous form of the disease, dengue hemorrhagic fever (DHF), U.S. Centers for Disease Control and Prevention (CDC) says in Morbidity and Mortality Weekly Report on August 10th. Doctors and health officials in parts of south Texas should be on the lookout for dengue fever, a tropical virus that can cause internal bleeding and death, CDC said on Aug 9th (http://www.msnbc.msn.com/id/20203770/).
